A PTH-related peptide (PTHRP) has been identified and its cDNA cloned from human tumors associated with the syndrome of humoral hypercalcemia of malignancy. The human PTHRP gene has been recently isolated and found to be a complex transcriptional unit using multiple promoters and containing alternatively spliced 3' exons which result in three mRNA classes, each class encoding a PTHRP with a unique carboxy-terminus. The PTHRP gene appears to be expressed in a number of normal tissues, and PTHRP transcripts have been previously reported to be overexpressed in a small sample of human parathyroid adenomas. In the present study we surveyed RNA prepared from a total of 60 abnormal human parathyroid glands for PTHRP gene expression using a combination of Northern blotting and RNase protection techniques. Apparent overexpression of PTHRP mRNA was observed in two thirds of parathyroid adenomas, whereas no overexpression was found in 7 examples of sporadic primary hyperplasia, 5 examples of secondary hyperplasia, and 3 examples of parathyroid carcinoma. Apparent overexpression was also observed in 1 of 4 cases of multiple endocrine neoplasia type 1, 1 of 2 examples of multiple endocrine neoplasia type 2, and 1 gland considered to represent tertiary hyperparathyroidism. Northern analysis of poly(A)+ RNA prepared from three representative adenomas using region-specific probes indicated that two putative promoters are used and revealed a pattern of preferential splicing of transcripts to include the most distal 3' exon. These findings suggest that the PTHRP gene is commonly overexpressed in adenomatous parathyroid glands, but not in sporadic primary hyperplasia, that this overexpression does not seem to be dependent on the use of a single specific promoter, and that adenomatous parathyroid cells appear to preferentially use one of several alternative splicing pathways. It is presently not known whether PTHRP is secreted by abnormal parathyroid tissues and, if so, in what form.

Download full-text PDF

Source
http://dx.doi.org/10.1210/jcem-69-6-1240DOI Listing

Publication Analysis

Top Keywords

pthrp gene
16
human parathyroid
12
parathyroid
9
pthrp
9
abnormal human
8
parathyroid tissues
8
parathyroid adenomas
8
rna prepared
8
parathyroid glands
8
apparent overexpression
8

Similar Publications

PTHrP Promotes RBP4 Expression Under the Control of PPARγ in the Kidney.

Int J Mol Sci

December 2024

Departamento de Ciencias Básicas de la Salud, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Avda. de Atenas s/n, 28922 Alcorcón, Madrid, Spain.

Article Synopsis
  • PTHrP and RBP4 are linked to worse kidney disease outcomes, and their relationship with PPARγ, a protective nuclear receptor, was investigated.
  • The study examined levels of these proteins in different mouse models, including controls, diabetics, and those overexpressing PTHrP.
  • Findings indicated that RBP4 and PTHrP levels increase during kidney pathology, suggesting that insulin and PPARγ play crucial roles in regulating their expression to maintain kidney health.
View Article and Find Full Text PDF

Heterodisomy in the locus is also a cause of pseudohypoparathyroidism type 1B (iPPSD3).

Front Endocrinol (Lausanne)

December 2024

Rare Disease Research Group, Molecular (Epi) Genetics Laboratory, Bioaraba Health Research Institute, Araba University Hospital, Vitoria-Gasteiz, Spain.

Objective: To identify the genetic cause underlying the methylation defect in a patient with clinical suspicion of PHP1B/iPPSD3.

Design: Imprinting is an epigenetic mechanism that allows the regulation of gene expression. The locus is one of the loci within the genome that is imprinted.

View Article and Find Full Text PDF

Bone is a common and debilitating site for metastatic cancer cell expansion. Skeletal metastasis is a multistage process, with primary stages of circulating tumour cells, progressing to a dormant state in vasculature and bone marrow niches, followed by tumourigenic reactivation, proliferation and finally bone destruction. The frequency of bone metastasis is reconciled in Paget's 'seed and soil' hypothesis, where a conducive microenvironment (bone niche) is essential for cancer cell colonisation.

View Article and Find Full Text PDF

d-limonene suppresses RANKL-induced osteoclast differentiation and promotes osteoblast activity in vitro.

Biosci Biotechnol Biochem

January 2025

Agri-Pharmacy Group, School of Biomedical Sciences, Faculty of Health, University of Plymouth, Plymouth, UK.

Article Synopsis
  • Osteoporosis treatments are usually implemented after fractures occur, so finding preventative methods to lower fracture risk is important.
  • D-limonene, a natural compound found in citrus fruits, has shown potential in promoting bone health by enhancing osteoblast activity and suppressing osteoclast formation, largely due to its effects on NFκB.
  • The study indicates that limonene not only supports the development of bone-forming cells but also decreases factors that lead to bone loss, suggesting it could be a useful supplement alongside existing osteoporosis treatments.
View Article and Find Full Text PDF

Role of hedgehog signaling in the pathogenesis and therapy of heterotopic ossification.

Front Cell Dev Biol

September 2024

The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.

Heterotopic ossification (HO) is a pathological process that generates ectopic bone in soft tissues. Hedgehog signaling (Hh signaling) is a signaling pathway that plays an important role in embryonic development and involves three ligands: sonic hedgehog (Shh), Indian hedgehog (Ihh) and desert hedgehog (Dhh). Hh signaling also has an important role in skeletal development.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!